ArticleJournal of racial and ethnic health disparities2026
Persistently Higher Ratio of Gallbladder Cancer Incidence in Native American People than in Non-Hispanic Whites: Selected United States Regions, 1962-2021.
Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundGallbladder carcinoma (GbCa) is the most frequent malignancy of the biliary tract in the United States (U.S.), with American Indians and Alaska Native (AIAN) people showing much higher incidence rates than Non-Hispanic Whites (NHW). This disparity was first reported more than six decades ago, with the greatest disparity occurring in the Southwest U.S. and Alaska. However, few up-to-date studies show changes in the magnitude of this disparity.
methodsWe conducted a literature review of 455 publications (1929–2018) and performed a meta-analysis of the disparity across the U.S., Alaska, and Southwest U.S. (1962–2011). We also examined recent data from the Arizona Cancer Registry (1995–2021) and New Mexico Tumor Registry (1995–2020). We followed guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), employing Cochrane’s RevMan 5.3 software.
resultsComparing GbCa incidence rates between AIANs and NHWs we found (1) all U.S. AIAN men and women had a 3.5- and 3-fold higher incidence rate, respectively. (2) Alaska and Southwest U.S. AIAN men and women had a 6- and 8.5-fold higher incidence rate, respectively. (3) Arizona AIAN men and women had an average 5.8- and 6.6-fold higher incidence rate, and New Mexico AIAN men and women had an average 6.1- and 6.0-fold higher incidence rate, respectively.
conclusionAIANs, particularly in the Southwest U.S., persistently experience over 5-fold higher GbCa incidence rates than NHWs, evidenced by recent data from Arizona and New Mexico. The implications from our study include developing and disseminating educational materials that will benefit AIANs in high-disparity regions, understanding the disparity at the pathological and clinical management levels, and setting forth a focused implementation agenda to reduce the incidence and mortality of GbCa in high-risk populations.
Identifiers
42024224What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.